These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 21254512)

  • 1. [Experience of joint administration of neuromidin and ovestin for correcting cognitive disorders in females with hypoestrogenic syndrome].
    Fedotova IuO
    Eksp Klin Farmakol; 2010 Oct; 73(10):34-6. PubMed ID: 21254512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined use of reminyl (galanthamine) and ovestin (oestradiol) for the treatment of cognitive disorders in women with hypoestrogenic syndrome].
    Sapronov NS; Fedotova IuO; Masalova OO; Losev NA
    Eksp Klin Farmakol; 2008; 71(3):36-9. PubMed ID: 18652255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficiacy of combined eglonil and avestin administration for pharmacocorrection of depressive disorders in women with hypoestrogenic syndrome].
    Sapronov NS; Fedotova IuO
    Eksp Klin Farmakol; 2009; 72(4):9-11. PubMed ID: 19803362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuromidin in the treatment of vascular cognitive disorders].
    Golovkova MS; Zakharov VV; Lifshits MIu; Iakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):20-6. PubMed ID: 18379458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of neuromidin in patients with minor ischemic stroke].
    Maksimova MIu; Sharov MN; Sineva NA; Vodop'ianov NP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 2):35-40. PubMed ID: 22224243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuromidin in the treatment of cognitive impairment in the early rehabilitation period of ischemic stroke].
    Pustokhanova LV; Morozova EM; Selivokhina OI; Shiliaeva EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(3 Pt 2):47-52. PubMed ID: 23612399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cognitive disorders in the early rehabilitation period of ischemic stroke and possibilities of their treatment with neuromidin].
    Pustokhanova LV; Morozova EM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(4 Pt 2):23-7. PubMed ID: 23120773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is cognitive functioning detrimentally affected after early, induced menopause?
    Vearncombe KJ; Pachana NA
    Menopause; 2009; 16(1):188-98. PubMed ID: 18724262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of chronic cystitis in postmenopausal women].
    Davidov MI; Petruniaev AI; Bunova NE
    Urologiia; 2009; (4):14-9. PubMed ID: 19824379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dementia following bipolar disorder].
    Lebert F; Lys H; Haëm E; Pasquier F
    Encephale; 2008 Dec; 34(6):606-10. PubMed ID: 19081458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia.
    Lee SW; Lee JG; Lee BJ; Kim YH
    Int Clin Psychopharmacol; 2007 Mar; 22(2):63-8. PubMed ID: 17293705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mood and neuropsychological changes in women with midlife depression treated with escitalopram.
    Wroolie TE; Williams KE; Keller J; Zappert LN; Shelton SD; Kenna HA; Reynolds MF; Rasgon NL
    J Clin Psychopharmacol; 2006 Aug; 26(4):361-6. PubMed ID: 16855452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation and mild cognitive impairment: what correlation?
    Puccio D; Novo G; Baiamonte V; Nuccio A; Fazio G; Corrado E; Coppola G; Muratori I; Vernuccio L; Novo S
    Minerva Cardioangiol; 2009 Apr; 57(2):143-50. PubMed ID: 19274024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical utility of the Mattis Dementia Rating Scale in assessing cognitive decline in Alzheimer's disease.
    Miller JM; Pliskin NH
    Int J Neurosci; 2006 May; 116(5):613-27. PubMed ID: 16644521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term use of ovestin by postmenopausal women with urinary incontinence].
    D'iakov VV; Godunov BN; Gvozdev MIu
    Urologiia; 2003; (1):43-6. PubMed ID: 12621967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of the Dementia Rating Scale-2 and cognitive enhancers in the diagnosis and treatment of cognitive disorders and dementia.
    Caston JC; Diehl LA; Hedgepath AW
    J S C Med Assoc; 2004 Feb; 100(2):32-8. PubMed ID: 15040232
    [No Abstract]   [Full Text] [Related]  

  • 18. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.
    Mishara AL; Goldberg TE
    Biol Psychiatry; 2004 May; 55(10):1013-22. PubMed ID: 15121486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: a meta-analysis of the current literature.
    Falleti MG; Maruff P; Burman P; Harris A
    Psychoneuroendocrinology; 2006 Jul; 31(6):681-91. PubMed ID: 16621325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial.
    Maki PM; Gast MJ; Vieweg AJ; Burriss SW; Yaffe K
    Neurology; 2007 Sep; 69(13):1322-30. PubMed ID: 17893293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.